X-152189843-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000808.4(GABRA3):c.1030G>A(p.Val344Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,206,033 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000019 ( 0 hom. 8 hem. )
Consequence
GABRA3
NM_000808.4 missense
NM_000808.4 missense
Scores
5
6
6
Clinical Significance
Conservation
PhyloP100: 7.86
Genes affected
GABRA3 (HGNC:4077): (gamma-aminobutyric acid type A receptor subunit alpha3) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA3 | NM_000808.4 | c.1030G>A | p.Val344Ile | missense_variant | 9/10 | ENST00000370314.9 | NP_000799.1 | |
GABRA3 | XM_006724811.4 | c.931+7790G>A | intron_variant | XP_006724874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA3 | ENST00000370314.9 | c.1030G>A | p.Val344Ile | missense_variant | 9/10 | 1 | NM_000808.4 | ENSP00000359337.4 | ||
GABRA3 | ENST00000535043.1 | c.1030G>A | p.Val344Ile | missense_variant | 9/10 | 1 | ENSP00000443527.1 | |||
GABRA3 | ENST00000497894.1 | n.101G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000450 AC: 5AN: 111004Hom.: 0 Cov.: 22 AF XY: 0.0000602 AC XY: 2AN XY: 33208
GnomAD3 genomes
AF:
AC:
5
AN:
111004
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33208
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000274 AC: 5AN: 182165Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66727
GnomAD3 exomes
AF:
AC:
5
AN:
182165
Hom.:
AF XY:
AC XY:
1
AN XY:
66727
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000192 AC: 21AN: 1095029Hom.: 0 Cov.: 29 AF XY: 0.0000222 AC XY: 8AN XY: 360479
GnomAD4 exome
AF:
AC:
21
AN:
1095029
Hom.:
Cov.:
29
AF XY:
AC XY:
8
AN XY:
360479
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000450 AC: 5AN: 111004Hom.: 0 Cov.: 22 AF XY: 0.0000602 AC XY: 2AN XY: 33208
GnomAD4 genome
AF:
AC:
5
AN:
111004
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33208
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
3
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at